Heart Problems and Cosentyx: What You Need to Know
Cosentyx, a medication prescribed for psoriasis and psoriatic arthritis, has been linked to an increased risk of heart problems in some patients. [1] According to the FDA, Cosentyx may cause inflammation of the heart, which can lead to serious complications, including heart failure and arrhythmias. [1]
What Types of Heart Problems Can Cosentyx Cause?
The most commonly reported heart-related issues associated with Cosentyx include:
* Inflammatory myocarditis, an inflammation of the heart muscle
* Pericarditis, an inflammation of the tissue surrounding the heart
* Heart failure, a condition where the heart cannot pump enough blood to meet the body's needs
How Common are Heart Problems with Cosentyx?
Clinical trials showed that about 1 in 1,000 patients treated with Cosentyx developed heart problems. [1] However, the FDA emphasizes that this risk may be higher in certain populations, such as those with pre-existing heart conditions or who are taking other medications that can increase the risk of heart problems. [1]
Who is at Risk for Cosentyx-Related Heart Problems?
Patients with a history of heart disease, high blood pressure, or high cholesterol may be more susceptible to heart problems associated with Cosentyx. [2] Additionally, those who have taken other medications that can increase the risk of heart problems, such as certain antihistamines or antidepressants, may also be at a higher risk.
What Should I Do if I'm Taking Cosentyx and Experience Heart Problems?
If you're taking Cosentyx and experience any symptoms of heart problems, such as chest pain, shortness of breath, or palpitations, seek medical attention immediately. Your doctor may monitor your heart health more closely or adjust your treatment plan to minimize the risk of heart problems.
Alternatives to Cosentyx
If you're concerned about the risk of heart problems associated with Cosentyx, discuss alternative treatment options with your doctor. Other medications, such as apremilast or secukinumab, may be suitable alternatives for treating psoriasis and psoriatic arthritis.
Sources:
[1] DrugPatentWatch.com: Cosentyx (secukinumab)
[2] National Institute of Arthritis and Musculoskeletal and Skin Diseases. Psoriatic Arthritis. 2022.